OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
49 hedge funds and large institutions have $223M invested in OptiNose in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 9 closing their positions.
77% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 13
8% more capital invested
Capital invested by funds: $207M → $223M (+$16.3M)
0.21% more ownership
Funds ownership: 29.53% → 29.73% (+0.21%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 53 → 49 (-4)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.48M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$2M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$1.52M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$925K |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$707K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.83M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$844K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$840K |
| 4 |
Neuberger Berman Group
New York
|
-$620K |
| 5 |
Goldman Sachs
New York
|
-$493K |
OPTN Hedge Fund Activity: Q1 2018 in Review
49 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q1 2018, worth a combined $223M — up 7.9% from $207M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of OPTN and 6 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 23 added.
The largest buyer was Ameriprise, adding an estimated $7.48M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $2.83M sold.
- 49 institutional investors held OptiNose (OPTN) as of Q1 2018, down from 53 in Q4 2017.
- Funds reported $223M of OptiNose stock for Q1 2018, up 7.9% quarter-over-quarter.
- 6 funds opened new OptiNose positions in Q1 2018 and 9 closed out, a net change of -3 holders.
- The largest OptiNose buyer in Q1 2018 was Ameriprise, an estimated $7.48M added.
- The largest OptiNose seller in Q1 2018 was Alyeska Investment Group, an estimated $2.83M sold.
Based on aggregated 13F filings for Q1 2018.